Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the STAY-C For Feed Market?

Over the past few years, the lenalidomide market has seen robust growth. The size of this market is expected to expand from $11.91 billion in 2024 to $12.79 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.4%. Several factors have contributed to the growth experienced in the historic period, including FDA approval for treating multiple myeloma, penetrating new geographic markets, the introduction of generic alternatives, advancements in clinical research and strategic collaborations. The increase in blood cancer prevalence, coupled with the rising demand for cost-effective treatments, has also propelled growth.

The market for lenalidomide is predicted to experience significant expansion in the coming years, with a projection to increase to “$16.88 billion in 2029, growing at a cumulative annual growth rate (CAGR) of 7.2%.” This promising forecast stems from several contributing factors, such as the rise in regulatory approvals for broader indications, a growing preference for targeted treatments, successful adoption in developing markets, increase in funds allocated to oncology investigation and advancement, as well as shifts towards combination treatment paradigms, and changes in healthcare guidelines advocating for affordable treatment solutions. The forecast period will likely see the rising trend of its adoption in new markets, increased attention towards combination treatments, a surge in the need for personalized medication strategies, regulatory changes impacting market trends, a growing reliance on real-world data for treatment choices, its usages extended beyond hematological cancers, and pricing strategies that shape the competitive market landscape.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15598&type=smp

Which Factor Is Shaping The Future Of The STAY-C For Feed Market?

The surge in demand for meat and poultry-based products is anticipated to stimulate the STAY-C for the feed market’s expansion. Meat consumption, encompassing seafood, fowl, and poultry items, plays a vital role in this development. STAY-C is integral in preserving the feed’s health and generating collagen to fortify muscles, vascular tissues, bones, and cartilage. For instance, The United States Department of Agriculture (USDA), a federal agency, reported in February 2023 that despite higher meat prices, consumers consumed roughly 227 pounds of poultry, beef, and pork on average in 2022, an increase from the 224.9 pounds in 2021. Thus, the rising demand for meat and poultry products is fueling the growth of the STAY-C for feed market.

The lenalidomide market covered in this report is segmented –

1) By Type: 5Mg Capsules, 10Mg Capsules, 15Mg Capsules, 25Mg Capsules

2) By Application: Multiple Myeloma (MM), Myelodysplastic Syndromes (MDS), Lymphoma, Other Applications

3) By End-User: Hospitals, Cancer Treatment Centers, Research Institutes

How Are Key Trends Driving Expansion In The STAY-C For Feed Industry?

Leading firms in the lenalidomide market are directing their efforts towards the creation of innovative medications, such as generic versions of lenalidomide capsules, in order to cater to the surging demand for affordable treatment alternatives and increase their market footprint. The generic variant of lenalidomide capsules is essentially a replica of the original drug with the same functionality. For example, Sandoz, a pharmaceutical corporation based in Switzerland, initiated the distribution of a generic lenalidomide version across 19 nations in Europe in February 2022. This drug is prescribed for various hemo-oncological conditions, in line with the most recent ESMO regulations. This yields a potential cost reduction for patients suffering from multiple myeloma, previously treated follicular lymphoma, transfusion-dependent anemia due to distinct myelodysplastic syndromes, and relapsed or refractory mantle cell lymphoma.

Which Companies Hold The Largest Market Share In The STAY-C For Feed Sector?

Major companies operating in the lenalidomide market are Bristol-Myers Squibb Company, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories, Cipla Limited, Apotex Inc., Zydus Lifesciences Limited, Alvogen, Lotus Pharmaceutical, Natco Pharma Limited, Accord Healthcare, Veranova, Avra Laboratories Pvt. Ltd., Camber Pharmaceuticals Inc., Rochem International Inc., Florencia Healthcare, Alleviare Life Sciences Pvt Ltd., LGM Pharma LLC, Sarv Biolabs Pvt Ltd., Speciality Medicines Private Limited, Healthiza Lifescience Private Limited.

https://www.thebusinessresearchcompany.com/report/lenalidomide-global-market-report

How Does Regional Performance Compare Across The STAY-C For Feed Industry?

North America was the largest region in the lenalidomide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lenalidomide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15598&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model